What is RPG Life Sciences Ltd. Quarterly Revenue?

RPG Life Sciences Ltd. Quarterly Revenue RPG Life Sciences Jun-2026 Quarterly Revenue is Rs 200 Cr which is growth of 14.8% YoY.

What is RPG Life Sciences Ltd. Quarterly Net Profit?

RPG Life Sciences Ltd. Quarterly Net Profit RPG Life Sciences Jun-2026 Quarterly Net Profit is Rs 31 Cr which is growth of 16.3% YoY.

What is RPG Life Sciences Ltd. Annual Revenue?

RPG Life Sciences Ltd. Annual Revenue RPG Life Sciences Mar-2026 Annual Revenue is Rs 733 Cr which is growth of 10.1% YoY.

What is RPG Life Sciences Ltd. Annual Net Profit?

RPG Life Sciences Ltd. Annual Net Profit RPG Life Sciences Mar-2026 Annual Net Profit is Rs 115 Cr which is growth of -37.1% YoY.

What is RPG Life Sciences Ltd. Total Shareholders Fund?

RPG Life Sciences Ltd. Total Shareholders Fund RPG Life Sciences Mar-2026 Total Shareholders Fund is Rs 605 Cr which is growth of 14.1% YoY.

What is RPG Life Sciences Ltd. Total Assets?

RPG Life Sciences Ltd. Total Assets RPG Life Sciences Mar-2026 Total Assets is Rs 793 Cr which is growth of 20.6% YoY.

What is RPG Life Sciences Ltd. Book Value Per Share?

RPG Life Sciences Ltd. Book Value Per Share RPG Life Sciences Mar-2026 Book Value Per Share is 366 Rs which is growth of 14.1% YoY.

What is RPG Life Sciences Ltd. ROE?

RPG Life Sciences Ltd. ROE RPG Life Sciences Mar-2026 ROE is 19% which is growth of 15.5% YoY.

What is RPG Life Sciences Ltd. Cash From Operating Activity?

RPG Life Sciences Ltd. Cash From Operating Activity RPG Life Sciences Mar-2026 Cash From Operating Activity is Rs 56 Cr which is growth of -27.4% YoY.

What is RPG Life Sciences Ltd. Net Cash Flow?

RPG Life Sciences Ltd. Net Cash Flow RPG Life Sciences Mar-2026 Net Cash Flow is Rs 87 Cr which is growth of 868.6% YoY.

RPG Life Sciences Ltd.

NSE: RPGLIFE | BSE: 532983

Expensive Rocket

Download real time

11.80(0.42%)

62.63% Gain from 52W Low

5,521

NSE+BSE Volume

NSE 14 Oct, 2026 3:31 PM (IST)

Portfolio

Alert

My Notes

RPG Life Sciences quarterly and annual financials: results, revenue, profit, P&L, balance sheet, cash flow, financial ratios, revenue mix, peer comparison, and financial documents

View Charts

Forecaster Analyst Estimates for RPG Life Sciences share price target, revenues, EPS, net income and more

RPG Life Sciences quarterly results: revenue, profit, and P&L – 13 quarter history

Nested row level

Base Level

Reporting Type

Standalone

Cell Data

Actual

Table Settings

YoY & New to Old

Nested row level

Base Level

Export

POSITIVE
Quarterly Revenue RPG Life Sciences Jun-2026 Quarterly Revenue is Rs 200 Cr which is growth of 14.8% YoY.
POSITIVE
Quarterly Net Profit RPG Life Sciences Jun-2026 Quarterly Net Profit is Rs 31 Cr which is growth of 16.3% YoY.

RPG Life Sciences Ltd., Quarterly, standalone, All financials are in INR Cr and price data in INR
Indicator	Jun '26	Mar '26	Dec '25	Sep '25	Jun '25	Mar '25	Dec '24	Sep '24	Jun '24	Mar '24	Dec '23	Sep '23	Jun '23
TOTAL_SR_Q Total Rev. ⌄	199.9	189.3	183.4	186.2	174.2	148.2	176	174.2	167.8	128.6	155.6	155.4	149.6
SR_Q Operating Rev.	195.7	176.9	180	181.7	168.9	143.1	172.7	172.2	165.4	127	153.7	153.6	147.8
OI_Q Other Income	4.2	12.4	3.4	4.5	5.2	5.1	3.3	1.9	2.4	1.7	1.9	1.8	1.8
OEXPNS_Q Operating Exp.	152.1	144	140.3	142.7	133.5	117.6	123.6	126.3	126.4	106.3	115.8	116.3	115.5
OEXPNS_Q Operating Exp.	152.1	144	140.3	142.7	133.5	117.6	123.6	126.3	126.4	106.3	115.8	116.3	115.5
OP_Q Operating Profit	43.6	32.9	39.8	39	35.5	25.5	49.2	45.9	39.1	20.7	37.9	37.3	32.2
OPMPCT_Q Operating Profit Margin %	22.27%	18.58%	22.09%	21.48%	21.00%	17.81%	28.46%	26.67%	23.62%	16.32%	24.66%	24.28%	21.82%
DEP_Q Depr.	5.9	5.7	5.4	5.2	5.1	5.4	5.5	5.3	5.3	4.5	4.1	4.2	4.2
INT_Q Interest	0.6	0.4	0.3	0.1	0.1	0.2	0.1	0.2	0.2	0.1	0.1	0.1	0.1
PBT_Q Profit Before Tax	41.2	40.2	29.1	49.5	35.4	134.9	46.9	15.1	36	17.7	35.5	34.8	29.8
TAX_Q Tax	10.6	10.3	7	12.6	9.1	17.6	12	10.9	9.2	4.5	9.1	8.9	7.7
NP_Q Net Profit	30.6	29.9	22.1	36.9	26.3	117.4	34.9	4.2	26.8	13.2	26.5	25.9	22.1
EPS_adj_Q EPS Adj. latest	18.5	18.1	13.4	22.3	15.9	71	21.1	2.5	16.2	8	16	15.6	13.4
NP_TTM Net profit TTM	119.5	115.2	202.6	215.4	182.8	183.2	79.1	70.7	92.3	87.7	84.8	77.4	71.5
EPS_TTM Basic EPS TTM	72.2	69.6	122.5	130.3	110.5	110.8	47.9	42.7	55.8	53	51.3	46.8	43.3
earnings_transcripts Earnings Transcripts
results_pdf Results PDF
result_notes Result Notes	Notes	Notes	Notes	Notes	Notes	Notes	Notes	Notes		Notes	Notes	Notes	Notes

*All financials are in INR Cr and price data in INR

Add metric to table

Search...

RPG Life Sciences competitor comparison and performance snapshot within industry

RPG Life Sciences annual results: revenue, profit, P&L, and margins as of Mar 2026 – 11 year history

Nested row level

Base Level

Reporting Type

Standalone

Cell Data

Actual

Table Settings

YoY & New to Old

CAGR Columns

Select...

Nested row level

Base Level

Export

POSITIVE
Annual Revenue RPG Life Sciences Mar-2026 Annual Revenue is Rs 733 Cr which is growth of 10.1% YoY.
NEGATIVE
Annual Net Profit RPG Life Sciences Mar-2026 Annual Net Profit is Rs 115 Cr which is growth of -37.1% YoY.

RPG Life Sciences Ltd., Annual, standalone, All financials are in INR Cr and price data in INR
Indicator	CAGR 3 Yrs	CAGR 5 Yrs	TTM	Mar '26	Mar '25	Mar '24	Mar '23	Mar '22	Mar '21	Mar '20	Mar '19	Mar '18	Mar '17	Mar '16
SR_A Total Rev. Ann. ⌄	12.3%	13.4%	758.8	733.1	666.1	589.3	517.6	443.2	390.1	376.3	331	344.9	294.3	280.1
TotalOperatingRevenues_A Operating Rev. Ann.	11.3%	12.7%	734.3	707.5	653.4	582.1	512.8	440.2	389.1	375.6	330.2	344	293.6	279.3
OI_A Other Income Ann.	74.5%	95.2%	24.5	25.5	12.7	7.2	4.8	3	0.9	0.7	0.8	1	0.6	0.8
OEXPNS_A Operating Exp. Ann.	11%	11.9%	579.1	560.4	493.8	453.9	410.1	353.8	319.2	316.4	296.6	306.4	265.9	255.8
OEXPNS_A Operating Exp. Ann.	11%	11.9%	579.1	560.4	493.8	453.9	410.1	353.8	319.2	316.4	296.6	306.4	265.9	255.8
OP_A Operating Profit Ann.	12.7%	16%	155.2	147.1	159.7	128.2	102.7	86.4	69.9	59.2	33.6	37.5	27.8	23.5
OPMPCT_A OPM Ann. %	0.4%	2.3%		20.07%	23.97%	21.75%	19.84%	19.49%	17.93%	15.72%	10.14%	10.88%	9.44%	8.38%
TotalExpenses_A Total Exp. Ann. ⌄	11%	11.6%		582.8	515.8	471.4	425.9	370	336.5	334.5	315.9	324.6	279.7	268.5
OtherExpenses_A Other Exp. Ann.	10.9%	12.3%	173.3	166.8	153.6	137.2	122.2	112	93.5	92.8	96.6	101.7	87.7	90.2
EmployeeBenefitExpenses_A Employee Exp. Ann.	6.5%	8.4%	145.5	141.5	126.1	132.2	117.1	100	94.7	95.9	89.9	90.1	75.6	74.1
CostOfPowerPurchased_A Cost Of Power Purchased Ann.	-	-
CostOfFuel_A Cost Of Fuel Ann.	-	-
EBIDT_A EBITDA Ann.	17.1%	19.5%		172.7	172.3	135.4	107.5	89.4	70.8	59.9	34.4	38.5	28.4	24.3
EBIDTPCT_A EBITDA Ann. margin %	4.3%	5.3%		23.55%	25.87%	22.97%	20.77%	20.16%	18.16%	15.91%	10.38%	11.16%	9.64%	8.66%
INT_A Interest Ann.	44.2%	2.4%	1.4	0.9	0.6	0.5	0.3	0.5	0.8	1.8	4	3.8	2.5	2.5
DEP_A Depr.	11.5%	5.4%	22.2	21.5	21.4	17.1	15.5	15.7	16.5	16.4	15.3	14.3	11.3	10.2
PBT_A PBT Ann.	18.9%	23.5%	160	154.2	232.9	117.8	91.7	73.2	53.6	36.5	15.1	20.4	14.5	11.6
TAX_A Tax Ann.	17.6%	23.5%	40.5	39	49.6	30.2	24	21.7	13.6	7.4	4.2	6.9	2.5
PAT_A PAT Before ExtraOrdinary Items Ann. ⌄	19.4%	23.6%		115.2	183.2	87.7	67.6	51.5	40	29	10.8	13.5	12.1	11.6
IncomeMinorityInterest_A Minority Interest Income Ann.	-	-		-	-	-	-	-	-	-	-	-	-	-
NP_A Net Profit Ann.	19.4%	23.6%	119.5	115.2	183.2	87.7	67.6	51.5	40	29	10.8	13.5	21	11.6
NETPCT_A NPM Ann. %	7.2%	9.6%		16.27%	28.04%	15.06%	13.19%	11.69%	10.27%	7.72%	3.27%	3.91%	7.15%	4.16%
EPS_adj_A EPS Adj. latest Ann.	19.4%	23.5%		69.6	110.8	53	40.9	31.1	24.2	17.5	6.5	8.1	12.7	7
result_notes Result Notes				Notes	Notes	Notes	Notes	Notes	Notes	Notes	Notes	Notes	Notes
Annual_Reports Annual Reports

*All financials are in INR Cr and price data in INR

Add metric to table

Search...

Total Rev. Ann.

1Y CHG

10.1%

2Y CAGR

11.5%

3Y CAGR

12.3%

5Y CAGR

13.4%

7Y CAGR

12%

10Y CAGR

10.1%

Total Revenue Annual growth is lower than historical averages.

Net Profit Ann.

1Y CHG

-37.1%

2Y CAGR

14.6%

3Y CAGR

19.4%

5Y CAGR

23.6%

7Y CAGR

40.2%

10Y CAGR

25.8%

Net Profit Annual is falling faster than historical averages.

Operating Exp. Ann.

1Y CHG

13.5%

2Y CAGR

11.1%

3Y CAGR

11%

5Y CAGR

11.9%

7Y CAGR

9.5%

10Y CAGR

8.2%

Operating Expenses Annual Cr growth is higher than historical averages.

RPG Life Sciences balance sheet as of Mar 2026: assets, liabilities, reserves, and borrowings – 11 year history

Nested row level

Base Level

Reporting Type

Standalone

Cell Data

Actual

Table Settings

YoY & New to Old

CAGR Columns

Select...

Nested row level

Base Level

Export

POSITIVE
Total Shareholders Fund RPG Life Sciences Mar-2026 Total Shareholders Fund is Rs 605 Cr which is growth of 14.1% YoY.
POSITIVE
Total Assets RPG Life Sciences Mar-2026 Total Assets is Rs 793 Cr which is growth of 20.6% YoY.

RPG Life Sciences Ltd., Balance Sheet, standalone, All financials are in INR Cr and price data in INR
Indicator	CAGR 3 Yrs	CAGR 5 Yrs	Mar '26	Mar '25	Mar '24	Mar '23	Mar '22	Mar '21	Mar '20	Mar '19	Mar '18	Mar '17	Mar '16
TotalShareHoldersFunds_A Total ShareHolders Funds Ann. ⌄	25.3%	22.8%	605.4	530.5	374.9	307.6	255.8	216.5	176.6	160.5	154.8	147	133.6
EQCAP_A Equity Share Capital Ann.	0%	0%	13.2	13.2	13.2	13.2	13.2	13.2	13.2	13.2	13.2	13.2	13.2
TotalShareCapital_A Total Share Capital Ann.	0%	0%	13.2	13.2	13.2	13.2	13.2	13.2	13.2	13.2	13.2	13.2	13.2
ReservesAndSurplus_A Reserves Plus Surplus Ann.	26.2%	23.8%	592.1	517.3	361.6	294.4	242.5	203.2	163.3	147.3	141.5	133.8	120.4
TotalReservesAndSurplus_A Total Reserves Plus Surplus Ann.	26.2%	23.8%	592.1	517.3	361.6	294.4	242.5	203.2	163.3	147.3	141.5	133.8	120.4
LiabilityMinorityInterest_A Minority Interest Liability Ann.	-	-	-	-	-	-	-	-	-	-	-	-	-
TotalNonCurrentLiabilities_A Total Non Current Liabilities Ann. ⌄	44.6%	30.1%	27.2	7.5	7.1	9	8.7	7.3	7.6	12.9	15.8	21.2	4.8
DeferredTaxLiabilities_A Deferred Tax Liabilities Ann.	15.7%	-	3.1			2	2.3
OtherLongTermLiabilities_A Other LongTerm Liabilities Ann.	4.3%	0%	3.4	2.9	3	3	3.4	3.4	3.3	3	2.8	2.8	2.6
CL_A Total Current Liabilities Ann. ⌄	16%	15%	160.5	119.8	131	102.8	80.1	79.7	82.6	77.8	120.7	78.7	66.8
TradePayables_A Trade Payables Ann.	14.5%	15.4%	97.2	79.4	71	64.7	45.5	47.4	44.4	25.1	51.9	28.7	33.7
OtherCurrentLiabilities_A Other Current Liabilities Ann.	1.6%	8.7%	27.5	24.3	47.8	26.2	20.2	18.1	20.3	13.3	18.7	14.9	10.2
ShortTermProvisions_A ST Provisions Ann.	34.7%	16.4%	29.1	16.1	12.2	11.9	14.2	13.6	12.8	10.3	12.3	11.1	1
TL_A Total Capital Plus Liabilities Ann.	23.7%	21.2%	793.1	657.8	512.9	419.4	344.6	303.4	266.7	251.2	291.3	246.9	205.2
FixedAssets_A Fixed Assets Ann. ⌄	13.7%	11.9%	219.8	187.9	209.8	149.7	134.8	125.1	132.9	144.8	139.5	138.5	110.9
TangibleAssets_A Tangible Assets Ann.	23.7%	19.6%	191.7	161.2	97	101.3	74.6	78.5	83.7	82.5	79.9	82.2	92.9
IntangibleAssets_A Intangible Assets Ann.	-40.7%	-32.7%	4.8	10.7	16.5	23	29.1	34.8	39.2	45.1	50.9	54.5	16.4
CapitalWorkInProgress_A Capital Work In Progress Ann.	10.1%	16.3%	20	4	84.8	15	25.5	9.4	7.3	10.1	4.8	1.8	1.6
TotalNonCurrentAssets_A Total Non Current Assets Ann. ⌄	20%	16.1%	268.5	192.6	214.8	155.3	137.7	127.5	141	154.2	148.7	150.5	118
NonCurrentInvestments_A Non Current Investments Ann.	-	-	35.8	1	1
DeferredTaxAssets_A Deferred Tax Assets Ann.	-	-26.3%		1	0.6			0.1	4.6	6.2	7.4	10.4
LongTermLoansAndAdvances_A LT Loans Plus Advances Ann.	-20.6%	-12.9%	0.1	0.2	0.2	0.2	0.2	0.2	0.2	0.1	0.1	0.1	7.2
OtherNonCurrentAssets_A Other Non Current Assets Ann.	33%	42%	12.7	2.5	3.2	5.4	2.8	2.2	3.3	3.1	1.6	1.5
CA_A Total Current Assets Ann. ⌄	25.7%	24.4%	524.7	465.3	298.1	264.1	206.9	175.9	125.8	97.1	142.6	96.4	87.2
CurrentInvestments_A Current Investments Ann.	12.8%	-	83.9	125.9	90.2	58.4
TradeReceivables_A Trade Receivables Ann.	46.1%	15.2%	116.7	86.8	49.1	37.4	33	57.4	63.3	38.9	68.1	39.3	37
CashAndCashEquivalents_A Cash Plus Cash Equivalents Ann.	40.1%	30.9%	156.8	139.6	36.5	57	70.3	40.8	1.1	0.8	0.9	1.6	0.8
ShortTermLoansAndAdvances_A ST Loans Plus Advances Ann.	-	-				0	0						10.4
OtherCurrentAssets_A Other Current Assets Ann.	39.3%	17.5%	43.5	20	21.3	16.1	20.7	19.4	14.7	16.4	19.9	9.7
TA_A Total Assets Ann.	23.7%	21.2%	793.1	657.8	512.9	419.4	344.6	303.4	266.7	251.2	291.3	246.9	205.2
ContingentLiabilities_A Contingent Liabilities plus Commitments Ann.	-1.6%	13.4%	31.9	15.2	22.3	33.5	15.1	17	14.2	11.7	11	4.8	6.2
BonusEquityShareCapital_A Bonus Equity Share Capital Ann.	-	-
NonCurrentInvestmentsUnquotedBookValue_A Non Current Investments Unquoted Book Value Ann.	-	-	35.8	1	1
CurrentInvestmentsUnquotedBookValue_A Current Investments Unquoted Book Value Ann.	12.8%	-	83.9	125.9	90.2	58.4

*All financials are in INR Cr and price data in INR

Add metric to table

Search...

Total Assets Ann.

1Y CHG

20.6%

2Y CAGR

24.4%

3Y CAGR

23.7%

5Y CAGR

21.2%

7Y CAGR

17.9%

10Y CAGR

14.5%

Total Assets Annual growth is stable compared to historical averages.

Total Current Liabilities Ann.

1Y CHG

34%

2Y CAGR

10.7%

3Y CAGR

16%

5Y CAGR

15%

7Y CAGR

10.9%

10Y CAGR

9.2%

Total Current Liabilities Annual Cr growth is higher than historical averages.

Total ShareHolders Funds Ann.

1Y CHG

14.1%

2Y CAGR

27.1%

3Y CAGR

25.3%

5Y CAGR

22.8%

7Y CAGR

20.9%

10Y CAGR

16.3%

Total ShareHolders Funds Annual growth is lower than historical averages.

RPG Life Sciences ROE, ROCE, book value, and debt-to-equity ratio as of Mar 2026 – 11 year history

Nested row level

Base Level

Reporting Type

Standalone

Cell Data

Actual

Table Settings

YoY & New to Old

CAGR Columns

Select...

Nested row level

Base Level

Export

POSITIVE
Book Value Per Share RPG Life Sciences Mar-2026 Book Value Per Share is 366 Rs which is growth of 14.1% YoY.
POSITIVE
ROE RPG Life Sciences Mar-2026 ROE is 19% which is growth of 15.5% YoY.

RPG Life Sciences Ltd., Ratios, standalone, All financials are in INR Cr and price data in INR
Indicator	CAGR 3 Yrs	CAGR 5 Yrs	Mar '26	Mar '25	Mar '24	Mar '23	Mar '22	Mar '21	Mar '20	Mar '19	Mar '18	Mar '17	Mar '16
BVSH_A BVSH Ann.	25.3%	22.8%	366.1	320.8	226.7	186	154.7	130.9	106.8	97.1	93.6	88.9	80.8
ROA_A RoA Ann. %	-3.4%	2%	14.52%	27.85%	17.09%	16.12%	14.93%	13.18%	10.87%	4.30%	4.61%	8.50%	5.66%
ROE_A ROE Ann. %	-4.7%	0.6%	19.02%	34.53%	23.38%	21.98%	20.12%	18.48%	16.42%	6.73%	8.69%	14.29%	8.69%
ROCE_A ROCE Ann. %	-6.3%	-0.3%	23.89%	28.04%	30.97%	29.05%	27.86%	24.30%	23.63%	10.97%	14.16%	10.14%	10.19%
ProfitabilityHeader Profitability Ratio ⌄
PBDITMargin_A EBITDA Ann. Margin %	5.2%	6%	24.40%	26.37%	23.25%	20.96%	20.29%	18.20%	15.94%	10.40%	11.19%	9.66%	8.68%
PBITMargin_A EBIT Ann. Margin %	6%	8.9%	21.36%	23.09%	20.32%	17.93%	16.74%	13.97%	11.58%	5.76%	7.02%	5.81%	5.05%
PBTMargin_A PBT Ann. Margin %	6.8%	9.6%	21.79%	35.63%	20.24%	17.87%	16.62%	13.76%	9.70%	4.55%	5.91%	4.95%	4.16%
NETPCT_A NPM Ann. %	7.2%	9.6%	16.27%	28.04%	15.06%	13.19%	11.69%	10.27%	7.72%	3.27%	3.91%	7.15%	4.16%
ASETTO_A Asset Turnover Ann. %	-8.4%	-6.5%	1	1.1	1.3	1.3	1.4	1.4	1.5	1.2	1.3	1.3	1.4
LiquidityHeader Liquidity Ratio ⌄
CRATIO_A Current Ratio Ann.	8.3%	8.4%	3.3	3.9	2.3	2.6	2.6	2.2	1.5	1.3	1.2	1.2	1.3
QuickRatio_A Quick Ratio Ann.	16%	10.8%	2.5	3.1	1.5	1.6	1.6	1.5	1	0.7	0.7	0.6	0.7
DividendPayoutNP_A Dividend Payout to NP Ann.	14.5%	-	0.3	0.1	0.2	0.2	0.2		0.4	0.4	0.3		0.3
EarningRetention_A Earning Retention Ann. %	-5%	-	65.54%	85.56%	77.36%	76.53%	76.87%		63.50%	63.28%	65.58%		77.20%
CashEarningRetention_A Cash Earning Retention Ann. %	-4.3%	-	70.96%	87.08%	81.05%	80.90%	82.27%		76.66%	84.81%	83.34%		87.83%
CashEarningRetention_A Cash Earning Retention Ann. %	-4.3%	-	70.96%	87.08%	81.05%	80.90%	82.27%		76.66%	84.81%	83.34%		87.83%
ValuationHeader Valuation Ratio ⌄
EnterpriseValue_A EnterpriseValue Ann.	38.8%	37.2%	2,922.9	3,626.9	2,494.1	1,093.8	855.6	600.7	287.4	444.6	679.9	782.3	389.2
EVPerNetSales_A EV Per Net Sales Ann.	25%	22.3%	4.1	5.6	4.3	2.1	1.9	1.5	0.8	1.4	2	2.7	1.4
PBV_A Price To Book Value Adjusted	-20.2%	-18.6%	7.7	12.29	12.43	15.15	18.22	21.53	26.39	29.04	30.12	31.7	34.89
EVPerEBITDA_A EV Per EBITDA Ann.	18.3%	14.7%	16.9	21.1	18.4	10.2	9.6	8.5	4.8	12.9	17.7	27.6	16
MarketCapPerSales_A Market Cap Per Sales Ann.	25%	21.9%	4.3	5.8	4.4	2.2	2.1	1.6	0.8	1.2	1.8	2.5	1.3
RetentionRatios_A Retention Ratio Ann. %	-5%	-	65.53%	85.55%	77.35%	76.52%	76.86%		63.49%	63.27%	65.57%		77.19%
EYield_A Earnings Yield Ann.	-	-	0	0.1	0	0.1	0.1	0.1	0.1	0	0	0	0
DEBT_CE_A Total Debt to Total Equity Ann.			0					0	0	0.2	0.3	0.3	0.2

*All financials are in INR Cr and price data in INR

Add metric to table

Search...

ROE Ann. %

1Y CHG

-44.9%

2Y CAGR

-9.8%

3Y CAGR

-4.7%

5Y CAGR

0.6%

7Y CAGR

16%

10Y CAGR

8.1%

ROE Annual % is falling faster than historical averages.

RoA Ann. %

1Y CHG

-47.9%

2Y CAGR

-7.8%

3Y CAGR

-3.4%

5Y CAGR

7Y CAGR

19%

10Y CAGR

9.9%

RoA Annual % is falling faster than historical averages.

Current Ratio Ann.

1Y CHG

-15.4%

2Y CAGR

19.8%

3Y CAGR

8.3%

5Y CAGR

8.4%

7Y CAGR

14.2%

10Y CAGR

9.8%

Current Ratio Annual is falling faster than historical averages.

RPG Life Sciences cash flow: net, operating, investing, and financing flows as of Mar 2026 – 11 year history

Nested row level

Base Level

Reporting Type

Standalone

Cell Data

Actual

Table Settings

YoY & New to Old

CAGR Columns

Select...

Nested row level

Base Level

Export

NEGATIVE
Cash From Operating Activity RPG Life Sciences Mar-2026 Cash From Operating Activity is Rs 56 Cr which is growth of -27.4% YoY.
POSITIVE
Net Cash Flow RPG Life Sciences Mar-2026 Net Cash Flow is Rs 87 Cr which is growth of 868.6% YoY.

RPG Life Sciences Ltd., Cash Flow, standalone, All financials are in INR Cr and price data in INR
Indicator	CAGR 3 Yrs	CAGR 5 Yrs	Mar '26	Mar '25	Mar '24	Mar '23	Mar '22	Mar '21	Mar '20	Mar '19	Mar '18	Mar '17	Mar '16
CFO_A Cash from Operating Act. Ann. ⌄	-14.6%	-0.6%	56.5	77.9	94.4	90.8	64.8	58.3	50.2	45.8	14.7	7.3	32.8
PBT_A PBT Ann.	18.9%	23.5%	154.2	232.9	117.8	91.7	73.2	53.6	36.5	15.1	20.4	14.5	11.6
INT_A Interest Ann.	44.2%	2.4%	0.9	0.6	0.5	0.3	0.5	0.8	1.8	4	3.8	2.5	2.5
TAX_A Tax Ann.	17.6%	23.5%	39	49.6	30.2	24	21.7	13.6	7.4	4.2	6.9	2.5
CFI_A Cash from Investing Act. Ann.	-	-	51.1	-41.8	-79.2	-105.8	-34.7	-8	-10.7	-19	-15.5	-30.1	-15.2
CFA_A Cash from Financing Act. Ann.	-	-	-20.6	-27.1	-20.3	-17.1	-13.5	-10.5	-39.3	-26.5	0.1	23.4	-17.6
NCF_A Net Cash Flow Ann. ⌄	-	16.9%	87	9	-5.1	-32.1	16.6	39.8	0.2	0.3	-0.8	0.6	0.1
CashAndCashEquivalentBeginOfYear_A Cash Plus Cash Eqv. Begin Of Year Ann.	-20.4%	124.8%	28.7	19.7	24.8	56.9	40.4	0.5	0.4	0.1	0.9	0.2	0.3
CashAndCashEquivalentEndOfYear_A Cash Plus Cash Eqv. End Of Year Ann.	67.1%	23.4%	115.7	28.7	19.7	24.8	56.9	40.4	0.5	0.4	0.1	0.9	0.3

*All financials are in INR Cr and price data in INR

Add metric to table

Search...

Cash from Operating Act. Ann.

1Y CHG

-27.5%

2Y CAGR

-22.6%

3Y CAGR

-14.6%

5Y CAGR

-0.6%

7Y CAGR

10Y CAGR

5.6%

Cash from Operating Activity Annual is falling faster than historical averages.

RPG Life Sciences investor presentations, annual reports, credit ratings, and earnings calls with AI summary, video, and audio access

Forecaster
Quarterly
Competitors/Peers
Annual
Balance Sheet
Ratios
Cash Flow
Documents

62.63% Gain from 52W Low

RPG Life Sciences quarterly and annual financials: results, revenue, profit, P&L, balance sheet, cash flow, financial ratios, revenue mix, peer comparison, and financial documents

RPG Life Sciences - Forecaster

Forecaster Analyst Estimates for RPG Life Sciences share price target, revenues, EPS, net income and more